Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Early ALT response to corticosteroid treatment distinguishes idiosyncratic Drug-induced Liver Injury from Autoimmune Hepatitis.

Weber S, Benesic A, Rotter I, Gerbes AL.

Liver Int. 2019 Jul 18. doi: 10.1111/liv.14195. [Epub ahead of print]

PMID:
31319011
2.

Ischemic Postconditioning (IPostC) Protects Fibrotic and Cirrhotic Rat Livers after Warm Ischemia.

Schewe J, Makeschin MC, Liss I, Mayr D, Zhang J, Khandoga A, Rothenfußer S, Schnurr M, Gerbes AL, Steib CJ.

Can J Gastroenterol Hepatol. 2019 Jun 9;2019:5683479. doi: 10.1155/2019/5683479. eCollection 2019.

3.

Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.

Reiter FP, Denk G, Ziesch A, Ofner A, Wimmer R, Hohenester S, Schiergens TS, Spampatti M, Ye L, Itzel T, Munker S, Teufel A, Gerbes AL, Mayerle J, De Toni EN.

Cell Oncol (Dordr). 2019 Jun 27. doi: 10.1007/s13402-019-00458-8. [Epub ahead of print]

PMID:
31250364
4.

Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support Causality.

Gerhardt F, Benesic A, Tillmann HL, Rademacher S, Wittekind C, Gerbes AL, Henker R, Berg T, Maidhof HP, Trauer H, Wiegand J.

Am J Gastroenterol. 2019 Jun 26. doi: 10.14309/ajg.0000000000000300. [Epub ahead of print] No abstract available.

PMID:
31246695
5.

[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].

Gerbes AL, Labenz J, Appenrodt B, Dollinger M, Gundling F, Gülberg V, Holstege A, Lynen-Jansen P, Steib CJ, Trebicka J, Wiest R, Zipprich A; Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV); Deutsche Gesellschaft für Innere Medizin e. V. (DGIM); Deutsche Gesellschaft für Infektiologie e. V. (DGI); Deutsche Gesellschaft für Pathologie e. V./Bundesverband deutscher Pathologen e. V. (DGP/BDP); Deutsche Röntgengesellschaft e. V. (DRG); Deutsche Gesellschaft für Interventionelle Radiologie und minimal-invasive Therapie (DeGIR); Deutsche Gesellschaft für Nephrologie (DGFN); Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM); Deutsche Gesellschaft für Neurologie e. V. (DGN); Deutsche Gesellschaft für Ernährungsmedizin e. V. (DGEM); Lebertransplantierte Deutschland e. V; Collaborators:.

Z Gastroenterol. 2019 May;57(5):e168. doi: 10.1055/a-0928-2800. Epub 2019 May 24. German. No abstract available.

PMID:
31127596
6.

Leitlinie Komplikationen der Leberzirrhose.

Gerbes AL, Labenz J.

Z Gastroenterol. 2019 May;57(5):571-573. doi: 10.1055/a-0873-4641. Epub 2019 May 13. German. No abstract available.

PMID:
31083745
7.

Leitlinienreport zur aktualisierten S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zu Komplikationen der Leberzirrhose.

Lynen Jansen P, Gerbes AL, Labenz J, Jungnitsch J, van Leeuwen P.

Z Gastroenterol. 2019 May;57(5):e121-e129. doi: 10.1055/a-0873-4682. Epub 2019 May 13. German. No abstract available.

PMID:
31083744
Free Article
8.

[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].

Gerbes AL, Labenz J, Appenrodt B, Dollinger M, Gundling F, Gülberg V, Holstege A, Lynen-Jansen P, Steib CJ, Trebicka J, Wiest R, Zipprich A; Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV); Deutsche Gesellschaft für Innere Medizin e. V. (DGIM); Deutsche Gesellschaft für Infektiologie e. V. (DGI); Deutsche Gesellschaft für Pathologie e. V./Bundesverband deutscher Pathologen e. V. (DGP/BDP); Deutsche Röntgengesellschaft e. V. (DRG); Deutsche Gesellschaft für Interventionelle Radiologie und minimal-invasive Therapie (DeGIR); Deutsche Gesellschaft für Nephrologie (DGFN); Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM); Deutsche Gesellschaft für Neurologie e. V. (DGN); Deutsche Gesellschaft für Ernährungsmedizin e. V. (DGEM); Lebertransplantierte Deutschland e. V; Collaborators:.

Z Gastroenterol. 2019 May;57(5):611-680. doi: 10.1055/a-0873-4658. Epub 2019 May 6. German. Erratum in: Z Gastroenterol. 2019 May;57(5):e168.

9.

Acute Liver Failure During Pirfenidone Treatment Triggered by Co-Medication With Esomeprazole.

Benesic A, Jalal K, Gerbes AL.

Hepatology. 2019 Apr 29. doi: 10.1002/hep.30684. [Epub ahead of print] No abstract available.

PMID:
31034631
10.

The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma.

Ye L, Mayerle J, Ziesch A, Reiter FP, Gerbes AL, De Toni EN.

Cell Death Discov. 2019 Apr 5;5:86. doi: 10.1038/s41420-019-0165-7. eCollection 2019.

11.

Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis.

Wieser A, Li H, Zhang J, Liss I, Markwardt D, Hornung R, Suerbaum S, Mayerle J, Gerbes AL, Steib CJ.

Dig Liver Dis. 2019 Mar 31. pii: S1590-8658(19)30101-X. doi: 10.1016/j.dld.2019.02.015. [Epub ahead of print]

PMID:
30944073
12.

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.

Trebicka J, Amoros A, Pitarch C, Titos E, Alcaraz-Quiles J, Schierwagen R, Deulofeu C, Fernandez-Gomez J, Piano S, Caraceni P, Oettl K, Sola E, Laleman W, McNaughtan J, Mookerjee RP, Coenraad MJ, Welzel T, Steib C, Garcia R, Gustot T, Rodriguez Gandia MA, Bañares R, Albillos A, Zeuzem S, Vargas V, Saliba F, Nevens F, Alessandria C, de Gottardi A, Zoller H, Ginès P, Sauerbruch T, Gerbes A, Stauber RE, Bernardi M, Angeli P, Pavesi M, Moreau R, Clària J, Jalan R, Arroyo V.

Front Immunol. 2019 Mar 19;10:476. doi: 10.3389/fimmu.2019.00476. eCollection 2019.

13.

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Fernández J, Clària J, Amorós A, Aguilar F, Castro M, Casulleras M, Acevedo J, Duran-Güell M, Nuñez L, Costa M, Torres M, Horrillo R, Ruiz-Del-Árbol L, Villanueva C, Prado V, Arteaga M, Trebicka J, Angeli P, Merli M, Alessandria C, Aagaard NK, Soriano G, Durand F, Gerbes A, Gustot T, Welzel TM, Salerno F, Bañares R, Vargas V, Albillos A, Silva A, Morales-Ruiz M, Carlos García-Pagán J, Pavesi M, Jalan R, Bernardi M, Moreau R, Páez A, Arroyo V.

Gastroenterology. 2019 Jul;157(1):149-162. doi: 10.1053/j.gastro.2019.03.021. Epub 2019 Mar 22.

14.

Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.

De Toni EN, Schlesinger-Raab A, Fuchs M, Schepp W, Ehmer U, Geisler F, Ricke J, Paprottka P, Friess H, Werner J, Gerbes AL, Mayerle J, Engel J.

Gut. 2019 Mar 16. pii: gutjnl-2018-318193. doi: 10.1136/gutjnl-2018-318193. [Epub ahead of print]

15.

Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.

Hernaez R, Kramer JR, Liu Y, Tansel A, Natarajan Y, Hussain KB, Ginès P, Solà E, Moreau R, Gerbes A, El-Serag HB, Kanwal F.

J Hepatol. 2019 Apr;70(4):639-647. doi: 10.1016/j.jhep.2018.12.018. Epub 2018 Dec 25.

PMID:
30590100
16.

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.

Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Wong F, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bhamidimarri KR, Boyer TD, Maevskaya M, Fassio E, Kim HS, Hwang JS, Gines P, Gadano A, Sarin SK, Angeli P; International Club of Ascites Global Study Group.

Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13.

PMID:
30552895
17.

Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.

Clària J, Moreau R, Fenaille F, Amorós A, Junot C, Gronbaek H, Coenraad MJ, Pruvost A, Ghettas A, Chu-Van E, López-Vicario C, Oettl K, Caraceni P, Alessandria C, Trebicka J, Pavesi M, Deulofeu C, Albillos A, Gustot T, Welzel TM, Fernández J, Stauber RE, Saliba F, Butin N, Colsch B, Moreno C, Durand F, Nevens F, Bañares R, Benten D, Ginès P, Gerbes A, Jalan R, Angeli P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif).

Hepatology. 2019 Apr;69(4):1686-1701. doi: 10.1002/hep.30363. Epub 2019 Mar 19.

PMID:
30521097
18.

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

Fernández J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, Deulofeu C, Garcia E, Acevedo J, Fuhrmann V, Durand F, Sánchez C, Papp M, Caraceni P, Vargas V, Bañares R, Piano S, Janicko M, Albillos A, Alessandria C, Soriano G, Welzel TM, Laleman W, Gerbes A, De Gottardi A, Merli M, Coenraad M, Saliba F, Pavesi M, Jalan R, Ginès P, Angeli P, Arroyo V; European Foundation for the Study of Chronic Liver Failure (EF-Clif).

J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2.

PMID:
30391380
19.

The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.

Op den Winkel M, Nagel D, Op den Winkel P, Paprottka PM, Schmidt L, Bourhis H, Trojan J, Goeller M, Reiter FP, Stecher SS, De Toni EN, Gerbes AL, Kolligs FT.

Digestion. 2019;100(1):15-26. doi: 10.1159/000493136. Epub 2018 Oct 3.

PMID:
30282074
20.

Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy.

Ardelt MA, Fröhlich T, Martini E, Müller M, Kanitz V, Atzberger C, Cantonati P, Meßner M, Posselt L, Lehr T, Wojtyniak JG, Ulrich M, Arnold GJ, König L, Parazzoli D, Zahler S, Rothenfußer S, Mayr D, Gerbes A, Scita G, Vollmar AM, Pachmayr J.

Hepatology. 2019 Jan;69(1):376-393. doi: 10.1002/hep.30190. Epub 2018 Dec 22.

21.

Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac.

Dragoi D, Benesic A, Pichler G, Kulak NA, Bartsch HS, Gerbes AL.

Front Pharmacol. 2018 Jul 4;9:699. doi: 10.3389/fphar.2018.00699. eCollection 2018.

22.

Herbal tea and liver injury - Tea extract or comedication can make a difference.

Benesic A, Gerbes AL.

J Hepatol. 2018 Aug;69(2):547-548. doi: 10.1016/j.jhep.2018.03.033. No abstract available.

PMID:
29776714
23.

Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury.

Benesic A, Rotter I, Dragoi D, Weber S, Buchholtz ML, Gerbes AL.

Clin Gastroenterol Hepatol. 2018 Sep;16(9):1488-1494.e5. doi: 10.1016/j.cgh.2018.04.049. Epub 2018 Apr 30. Erratum in: Clin Gastroenterol Hepatol. 2019 Apr;17(5):1008.

PMID:
29723689
24.

Benefit in liver transplantation: a survey among medical staff, patients, medical students and non-medical university staff and students.

Englschalk C, Eser D, Jox RJ, Gerbes A, Frey L, Dubay DA, Angele M, Stangl M, Meiser B, Werner J, Guba M.

BMC Med Ethics. 2018 Feb 12;19(1):7. doi: 10.1186/s12910-018-0248-7.

25.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Hüsing-Kabar A, Solà E, Gerbes A, Bernardi M, Alessandria C, Scheiner B, Tonon M, Maschmeier M, Solè C, Trebicka J, Gustot T, Nevens F, Arroyo V, Gines P, Angeli P; EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure (EF Clif).

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.

PMID:
29391267
26.

Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, Nault JC, Avila MA.

Gut. 2018 Feb;67(2):380-388. doi: 10.1136/gutjnl-2017-315068. Epub 2017 Nov 17. Erratum in: Gut. 2018 Mar;67(3):594.

27.

[How to deal with increased liver markers].

Rust C, Gerbes A.

MMW Fortschr Med. 2017 Nov;159(19):68-70. doi: 10.1007/s15006-017-0283-1. Review. German. No abstract available.

PMID:
29124577
28.

Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.

Op den Winkel M, Nagel D, Op den Winkel P, Trojan J, Paprottka PM, Steib CJ, Schmidt L, Göller M, Stieber P, Göhring P, Herbst A, Rentsch M, De Toni EN, Göke B, Gerbes AL, Kolligs FT.

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):44-53. doi: 10.1097/MEG.0000000000001005.

PMID:
29076939
29.

Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.

Münch S, Habermehl D, Agha A, Belka C, Combs SE, Eckel R, Friess H, Gerbes A, Nüssler NC, Schepp W, Schmid RM, Schmitt W, Schubert-Fritschle G, Weber B, Werner J, Engel J.

Strahlenther Onkol. 2018 Feb;194(2):125-135. doi: 10.1007/s00066-017-1225-7. Epub 2017 Oct 25.

PMID:
29071366
30.

Data on chow, liver tissue and mitochondrial fatty acid compositions as well as mitochondrial proteome changes after feeding mice a western diet for 6-24 weeks.

Einer C, Hohenester S, Wimmer R, Wottke L, Artmann R, Schulz S, Gosmann C, Simmons A, Leitzinger C, Eberhagen C, Borchard S, Schmitt S, Hauck SM, von Toerne C, Jastroch M, Walheim E, Rust C, Gerbes AL, Popper B, Mayr D, Schnurr M, Vollmar AM, Denk G, Zischka H.

Data Brief. 2017 Sep 18;15:163-169. doi: 10.1016/j.dib.2017.09.019. eCollection 2017 Dec.

31.

Cell death markers in patients with cirrhosis and acute decompensation.

Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, Zheng YB, Gronbaek H, Gerbes AL, Sola E, Caraceni P, Moreau R, Gines P, Arroyo V, Jalan R.

Hepatology. 2018 Mar;67(3):989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24.

PMID:
29023872
32.

Mitochondrial adaptation in steatotic mice.

Einer C, Hohenester S, Wimmer R, Wottke L, Artmann R, Schulz S, Gosmann C, Simmons A, Leitzinger C, Eberhagen C, Borchard S, Schmitt S, Hauck SM, von Toerne C, Jastroch M, Walheim E, Rust C, Gerbes AL, Popper B, Mayr D, Schnurr M, Vollmar AM, Denk G, Zischka H.

Mitochondrion. 2018 May;40:1-12. doi: 10.1016/j.mito.2017.08.015. Epub 2017 Sep 19.

PMID:
28935446
33.

Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.

Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R, Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes AL.

Hepatology. 2017 Oct;66(4):1232-1241. doi: 10.1002/hep.29290. Epub 2017 Aug 26.

PMID:
28545169
34.

Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient.

De Toni EN, Gerbes AL.

Gastroenterology. 2017 May;152(6):1631-1633. doi: 10.1053/j.gastro.2017.01.063. Epub 2017 Apr 4. No abstract available.

PMID:
28384452
35.

Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP.

Gut. 2017 Jun;66(6):1154-1164. doi: 10.1136/gutjnl-2016-313369. Epub 2017 Mar 23. Review.

36.

Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol.

Steib CJ, Gerbes AL.

Hepatol Int. 2017 Mar;11(2):141-142. doi: 10.1007/s12072-017-9791-4. Epub 2017 Feb 23. No abstract available.

PMID:
28233256
37.

Diagnosis and treatment of ascites.

Tsochatzis EA, Gerbes AL.

J Hepatol. 2017 Jul;67(1):184-185. doi: 10.1016/j.jhep.2017.01.011. Epub 2017 Jan 22. No abstract available.

PMID:
28119010
38.

Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality.

Busk TM, Møller S, Pedersen EB, Gerbes A, Krag A, Peck-Radosavljevic M, Frankova S, Coenraad MJ, Bendtsen F.

J Gastroenterol Hepatol. 2017 May;32(5):1087-1093. doi: 10.1111/jgh.13641.

PMID:
28092112
39.

Reliable Quantification of the Potential for Equations Based on Spot Urine Samples to Estimate Population Salt Intake: Protocol for a Systematic Review and Meta-Analysis.

Huang L, Crino M, Wu JH, Woodward M, Land MA, McLean R, Webster J, Enkhtungalag B, Nowson CA, Elliott P, Cogswell M, Toft U, Mill JG, Furlanetto TW, Ilich JZ, Hong YH, Cohall D, Luzardo L, Noboa O, Holm E, Gerbes AL, Senousy B, Pinar Kara S, Brewster LM, Ueshima H, Subramanian S, Teo BW, Allen N, Choudhury SR, Polonia J, Yasuda Y, Campbell NR, Neal B, Petersen KS.

JMIR Res Protoc. 2016 Sep 21;5(3):e190. doi: 10.2196/resprot.6282.

40.

Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.

Clària J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, Amorós À, Titos E, Alcaraz-Quiles J, Oettl K, Morales-Ruiz M, Angeli P, Domenicali M, Alessandria C, Gerbes A, Wendon J, Nevens F, Trebicka J, Laleman W, Saliba F, Welzel TM, Albillos A, Gustot T, Benten D, Durand F, Ginès P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-CLIF Consortium and the European Foundation for the Study of Chronic Liver Failure (EF-CLIF).

Hepatology. 2016 Oct;64(4):1249-64. doi: 10.1002/hep.28740. Epub 2016 Aug 25.

41.

Liver Cirrhosis and Kidney.

Gerbes AL.

Dig Dis. 2016;34(4):387-90. doi: 10.1159/000444553. Epub 2016 May 11.

PMID:
27170393
42.

Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.

Reiter FP, Wimmer R, Wottke L, Artmann R, Nagel JM, Carranza MO, Mayr D, Rust C, Fickert P, Trauner M, Gerbes AL, Hohenester S, Denk GU.

World J Hepatol. 2016 Mar 18;8(8):401-10. doi: 10.4254/wjh.v8.i8.401.

43.

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.

Ariza X, Graupera I, Coll M, Solà E, Barreto R, García E, Moreira R, Elia C, Morales-Ruiz M, Llopis M, Huelin P, Solé C, Fabrellas N, Weiss E, Nevens F, Gerbes A, Trebicka J, Saliba F, Fondevila C, Hernández-Gea V, Fernández J, Bernardi M, Arroyo V, Jiménez W, Deulofeu C, Pavesi M, Angeli P, Jalan R, Moreau R, Sancho-Bru P, Ginès P; CANONIC Investigators, EASL CLIF Consortium.

J Hepatol. 2016 Jul;65(1):57-65. doi: 10.1016/j.jhep.2016.03.002. Epub 2016 Mar 14.

44.

Rescue management of early complications after liver transplantation-key for the long-term success.

Andrassy J, Wolf S, Hoffmann V, Rentsch M, Stangl M, Thomas M, Pratschke S, Frey L, Gerbes A, Meiser B, Angele M, Werner J, Guba M.

Langenbecks Arch Surg. 2016 May;401(3):389-96. doi: 10.1007/s00423-016-1398-z. Epub 2016 Mar 10.

PMID:
26960592
45.

Automated low flow pump system for the treatment of refractory ascites: a single-center experience.

Thomas MN, Sauter GH, Gerbes AL, Stangl M, Schiergens TS, Angele M, Werner J, Guba M.

Langenbecks Arch Surg. 2015 Dec;400(8):979-83. doi: 10.1007/s00423-015-1356-1. Epub 2015 Nov 13.

PMID:
26566989
46.

Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.

Khandoga A, Iskandarov E, Angele M, Gerbes A, Frey L, Ağayev B, Jauch KW, Werner J, Guba M.

Eur J Gastroenterol Hepatol. 2016 Feb;28(2):153-8. doi: 10.1097/MEG.0000000000000505.

PMID:
26545081
47.

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.

Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S.

Gut. 2015 Nov;64(11):1824-33. doi: 10.1136/gutjnl-2015-310421. Review.

48.

Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1.

Lu S, Török HP, Gallmeier E, Kolligs FT, Rizzani A, Arena S, Göke B, Gerbes AL, De Toni EN.

Oncotarget. 2015 Sep 8;6(26):22167-78.

49.

Infection as a Trigger for Portal Hypertension.

Steib CJ, Schewe J, Gerbes AL.

Dig Dis. 2015;33(4):570-6. doi: 10.1159/000375352. Epub 2015 Jul 6.

PMID:
26159275
50.

Drug-Induced Liver Injury and Individual Cell Models.

Benesic A, Gerbes AL.

Dig Dis. 2015;33(4):486-91. doi: 10.1159/000374094. Epub 2015 Jul 6.

PMID:
26159263

Supplemental Content

Loading ...
Support Center